Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 6, 1998
Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study GroupJ M Frazao, R W Chesney, J W CoburnNephron|January 1, 1995
Carbamylated hemoglobin in prerenal azotemiaJ M Frazao, R H Barth, G M BerlyneNephron|January 1, 1994
Persistence of antibodies to hepatitis C virus in a chronic hemodialysis populationF Carrera, J G Silva, C Oliveira, et al.Kidney International|July 8, 2000
A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidismW G Goodman, J M Frazao, D A Goodkin, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 26, 2009
Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patientsT Adragao, J Herberth, M-C Monier-Faugere, et al.Pageof 1